Get it on Google Play

ANI Pharmaceuticals reports positive phase 4 uveitis trial data

October 12, 2026 6:55 AM EDT Send to a Friend
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) announced results from its SYNCHRONICITY Phase 4 clinical trial evaluating a fluocinolone acetonide intravitreal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login